位置:成果数据库 > 期刊 > 期刊详情页
CC趋化因子受体-2在肝细胞肝癌组织中的表达及临床意义
  • ISSN号:1007-8118
  • 期刊名称:中华肝胆外科杂志
  • 时间:2013.9.12
  • 页码:686-690
  • 分类:R512.91[医药卫生—临床医学;医药卫生—内科学]
  • 作者机构:[1]第四军医大学西京医院肝胆外科,西安710032
  • 相关基金:陕西省自然科学基金资助项目(2011K3-03-04);国家自然科学基金资助项目(81172061/H1607)
  • 相关项目:MiR-200a/ZEB通路参与肝癌干细胞的产生和转移的机制研究
作者: 段涛|李海民|
中文摘要:

目的研究CC趋化因子受体-2(CC chemokine receptor2,CCR-2)在肝细胞癌组织中的表达及其与肝癌临床病理特征、预后的关系。方法用免疫组织化学法(SP法)检测76例肝癌组织及其癌旁组织中CCR2的表达情况,分析CCR-2表达与肝癌各项临床病理特征以及患者预后的关系。CCR-2染色结果与各项临床指标的关系采用Х^2检验或Fisher确切概率法检验。采用KaplanMeier法绘制生存曲线。生存情况分析采用lo~rank检验。结果14(18.40A)例癌旁组织CCR-2染色结果显示为弱阳性表达,其余均为阴性。在肝癌组织中,CCR2表达明显高于癌旁组织:15(19.7%)例阴性表达,29(38.2%)例弱阳性表达,12(15.8%)例中等阳性表达,20(26.3%)例强阳性表达。肝癌组织中CCR2阳性表达与肿瘤直径(Х^2=12.41,P〈0.01)、门静脉癌栓(Х^2=7.476,P=0.006)、转移(Х^2=7.227,P=0.007)、AJCC分期(Х^2=20.711,P〈0.01)明显相关。CCR2高表达组患者术后五年生存率(6.3%)明显低于低表达组(38.6%),差异具有统计学意义(Х^2=27.133,P%0.01)。经单因素及多因素分析显示,肝癌组织CCR-2高表达是影响肝癌患者总体生存的独立危险因素(P〈0.05)。结论CCR-2在肝癌组织中表达明显升高,可能参与了肝癌的发生发展过程,检测CCR-2表达水平对判断肝癌的预后具有一定的参考价值。

英文摘要:

Objective To investigate the expression of CC chemokine receptor 2 (CCR-2) in hepatocellular carcinoma (HCC) and to evaluate its relationship with the clinicopathological features and prognosis of HCC. Methods Immunohistochemistry was used to detect the expression of CCR 2 in the HCC tissues and their corresponding non-cancerous adjacent liver tissues in 76 patients with HCC. Statistical analysis was used to determine the association of CCR 2 expression with clinicopatho- logical features and prognosis. The expressions of CCR 2 and the relationship between CCR 2 expression and clinicopathological features and prognosis were analyzed using the Chi-square test and Fisher exact probability test. The survival curve was drawn using the Kaplan-Meier method, and the survival was analyzed using the log-rank test. Results Weak positive staining of CCR-2 was detected in the non-cancerous adjacent liver tissues of 14 samples (18.4%) and negative staining was detected in the non-cancerous adjacent liver tissues of the remaining samples. The expression of CCR-2 was different in the HCC tissues: negative CCR-2 was detected in 15(19.7%) samples, weak positive staining of CCR-2 in 29 (38.2%~) samples, moderate positive staining of CCR-2 in 12 (15.8%) samples, and strong positive staining of CCR 2 in 20(26.3%) samples. The high expression of CCR-2 strongly correlated with tumor size (Х^2=12.41,P〈0.01), venous invasion (Х^2=7. 476,P=0. 006), metastasis (Х^2=7.227,P=0.007) and AJCC TNM stage (Х^2=20. 711,P〈0. 01). The cumulative 5 year survival rate was 38.6% in the low CCR-2 expression group, whereas it was 6.3%in the high CCR-2 expression group (Х^2= 27. 133,P〈0.01). Univariate analysis and multivariate analysis showed that high CCR 2 expression was an independent predictor of overall survival of HCC (P〈0.05). Conclusions The expression of CCR 2 is highly up-regulated in HCC tissues, indicating that high CCR 2 expression is involved in the process of HCC carcinoge

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中华肝胆外科杂志》
  • 北大核心期刊(2011版)
  • 主管单位:中国科学技术协会
  • 主办单位:中华医学会
  • 主编:卢实春
  • 地址:北京市东四西大街42号
  • 邮编:100710
  • 邮箱:zhgdwkzz@vip.163.com
  • 电话:010-85158180
  • 国际标准刊号:ISSN:1007-8118
  • 国内统一刊号:ISSN:11-3884/R
  • 邮发代号:82-857
  • 获奖情况:
  • 国内外数据库收录:
  • 美国化学文摘(网络版),波兰哥白尼索引,中国中国科技核心期刊,中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版)
  • 被引量:23337